Nuvation Bio (NUVB) Receivables (2024 - 2025)
Historic Receivables for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $13.8 million.
- Nuvation Bio's Receivables rose 22572.91% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 22572.91%. This contributed to the annual value of $16.3 million for FY2024, which is 34008.64% up from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Receivables is $13.8 million, which was up 22572.91% from $6.7 million recorded in Q2 2025.
- Nuvation Bio's Receivables' 5-year high stood at $16.3 million during Q4 2024, with a 5-year trough of $3.7 million in Q4 2023.
- Moreover, its 3-year median value for Receivables was $5.5 million (2025), whereas its average is $7.7 million.
- Its Receivables has fluctuated over the past 5 years, first skyrocketed by 34008.64% in 2024, then surged by 6642.57% in 2025.
- Nuvation Bio's Receivables (Quarter) stood at $3.7 million in 2023, then skyrocketed by 340.09% to $16.3 million in 2024, then decreased by 14.99% to $13.8 million in 2025.
- Its last three reported values are $13.8 million in Q3 2025, $6.7 million for Q2 2025, and $5.5 million during Q1 2025.